Stem Cell Therapy Needs More Than Just The Cells: Device Firms See Opening
This article was originally published in The Pink Sheet Daily
Thermogenesis and Cytori Therapeutics are two firms that could benefit.
You may also be interested in...
TOKYO - Sidetracking the human embryonic stem cell debate in the U.S., Astellas entered a strategic relationship with San Diego firm Cytori Therapeutics, a regenerative medicine company that relies mainly on adipose-derived - or fat-derived - stem cells from patients
The high-profile COURAGE trial again raises the question of how soon stents should be placed in patients with coronary disease.